A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine

Clinical trial NCT00644033 · COMPLETED

Trial details

NCT number: NCT00644033
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Menstrually Associated Migraine

Start date: 2001-06-01
Primary completion: 2002-06-01
Enrollment: 579

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.